K2VITAL Delta banner promoting patented microencapsulated Vitamin K2, featuring a bright green light burst and “Vitamin K2, Done Right” messaging.
Home
Vitamin C May Decrease COPD...

Vitamin C May Decrease COPD and Pneumonia Prognosis Inflammatory Diseases

30 Oct 2006
Add nutritioninsight as a preferred source on Google
Image

It is suggested that the elevation of vitamin C in serum is a good prognostic parameter for disease evaluation.

30/10/06 During exacerbation, vitamin C is markedly decreased in inflammatory diseases, such as acute pneumonia and COPD, according to a new study. Serbian researchers compared the values of serum ascorbate concentration and laboratory inflammation indicators in 60 nonsmoking patients. The patients were split into three groups: 20 patients with acute pneumonia (group I), 20 patients with stable COPD (group II), and 20 patients with exacerbated COPD (group III). Researchers concluded that patients in groups I and III had significantly decreased levels of vitamin C and increased inflammation before therapy, compared with patients after therapy. It is suggested that the elevation of vitamin C in serum is a good prognostic parameter for disease evaluation.

All content and features on this website are copyrighted with all rights reserved. The full details can be found in our privacy statement
Add nutritioninsight as a preferred source on Google
Save in your AIChatGPTGoogle AIClaudePerplexityGrok
Subscribe to our newsletters
PlatformsFood Ingredients FirstNutrition InsightPackaging InsightsPersonal Care InsightsThe World of Food Ingredients
About usContact usAdvertisingPrivacy statementSitemapArchiveEditorial Team
Follow us
Image